Vaccine Analytical Research & Development, 770 Sumneytown Pike, P. O. Box 4, West Point, PA, WP46-3305, 19486, USA.
Small Molecule Analytical Research & Development, Analytical Research & Development Merck & Co., Inc, Rahway, NJ, USA.
Glycoconj J. 2023 Oct;40(5):565-573. doi: 10.1007/s10719-023-10125-8. Epub 2023 Jul 4.
Streptococcus pneumoniae is a highly invasive bacterial pathogen that can cause a range of illnesses. Pneumococcal capsular polysaccharides (CPS) are the main virulence factors that causes invasive pneumococcal disease (IPD). Pneumococcal CPS serotype 7F along with a few other serotypes is more invasive and likely to cause IPD. Therefore, 7F is a target for pneumococcal vaccine development, and is included in the two recently approved multi-valent pneumococcal conjugated vaccines, i.e. VAXNEUVANCE and PREVNAR 20.To support process and development of our 15-valent pneumococcal conjugated vaccine (PCV15), chromatographic methods have been developed for 7F polysaccharide and conjugate characterization. A size-exclusion chromatography (SEC) method with UV, light scattering and refractive index detections was employed for concentration, size and conformation analysis. A reversed-phase ultra-performance liquid chromatography (RP-UPLC) method was used for analysis of conjugate monosaccharide composition and degree of conjugation. The collective information obtained by these chromatographic analysis provided insights into the pneumococcal conjugate and conjugation process.
肺炎链球菌是一种高度侵袭性的细菌病原体,可引起多种疾病。肺炎球菌荚膜多糖(CPS)是引起侵袭性肺炎球菌病(IPD)的主要毒力因子。肺炎球菌 CPS 血清型 7F 以及其他少数几种血清型更具侵袭性,可能导致 IPD。因此,7F 是肺炎球菌疫苗开发的目标,并且包含在最近批准的两种多价肺炎球菌结合疫苗中,即 VAXNEUVANCE 和 PREVNAR 20。为了支持我们的 15 价肺炎球菌结合疫苗(PCV15)的工艺和开发,已经开发了用于 7F 多糖和缀合物表征的色谱方法。采用带有紫外、光散射和折射率检测的尺寸排阻色谱(SEC)方法进行浓度、大小和构象分析。反相超高效液相色谱(RP-UPLC)方法用于分析缀合物单糖组成和缀合度。这些色谱分析获得的综合信息提供了对肺炎球菌缀合物和缀合过程的深入了解。